Navigation Links
Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®
Date:4/3/2011

NEW ORLEANS, April 3, 2011 /PRNewswire/ -- A pooled analysis of the SPIRIT II, III, IV and COMPARE trials presented today further reinforces the positive clinical performance of Abbott's (NYSE: ABT) market-leading XIENCE V® Everolimus Eluting Coronary Stent System. As part of the analysis of all four trials, two-year results on the safety and efficacy of XIENCE V compared to TAXUS® Liberte® and TAXUS® Express2™ Paclitaxel-Eluting Coronary Stent Systems (TAXUS) were presented at the American College of Cardiology's (ACC) 60th Annual Scientific Session and i2 Summit 2011 in New Orleans.

In a presentation given by Dean J. Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center in Cincinnati, Ohio, predictors of artery re-blockage, cardiac death or heart attack were evaluated out to two years in nearly 7,000 patients from the SPIRIT II, III, IV and COMPARE clinical trials. The data demonstrated that use of XIENCE V resulted in significantly lower clinical event rates following a stent procedure. In the pooled analysis, XIENCE V demonstrated a 36 percent reduction in the risk of major adverse cardiac events (MACE) compared to TAXUS (7.3 percent for XIENCE V versus 11.1 percent for TAXUS, p-value<0.001). MACE is an important composite clinical measure of safety and efficacy outcomes for patients, defined as cardiac death, heart attack (myocardial infarction or MI), or retreatment of a lesion (ischemia-driven target lesion revascularization, or ID-TLR).

"XIENCE V consistently demonstrated low adverse cardiac event rates in trial after trial," said Dr. Kereiakes. "The SPIRIT II, III, IV, and COMPARE pooled analysis suggests that XIENCE V reduced the occurrence of adverse events compared to patients treated with the TAXUS stent. The low event rates demonstrated by XIENCE V in these trials are esp
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis
2. "The State of the Medical Marijuana Markets 2011" First Ever Investor-Grade Analysis Report of the Marijuana Marketplace in the United States
3. Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Pancreatic Cancer
4. Reportlinker Adds Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma
5. Applied Science Laboratories Releases Revolutionary Eye Tracking Analysis Software
6. RainDance Technologies and Ambry Genetics Expand Collaboration to Address ADME Analysis
7. InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA
8. Analysis of Calipers Phase I EPA ToxCast™ Data Published in Leading Scientific Journal
9. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
10. Reportlinker Adds U.S. Pain Management Products & Services: a Market Analysis - 7th Edition
11. Reportlinker Adds Generic and innovative drug market in CE countries 2011 - Comparative analysis, reimbursement policies and development forecasts for 2011-2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... its orally ingestible insulin capsule on type 1 diabetic ... the ADA 75 th Scientific Sessions on June ... poster will be attended by Oramed,s Chief Scientific Officer, ...
(Date:6/2/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached an agreement to settle ... Delaware Court of Chancery, which names as ... directors and officers, and names the Company as a ... re CytRx Corp. Stockholder Derivative Litigation , C.A. No. ...
(Date:6/2/2015)...  Ashion™ Advanced Individual Medicine™ (AIM), a ... industry, announced today the launch of its ... Medicine Platform. AIM develops and manages comprehensive ... healthcare systems, providing these centers with clinical ... operational support. AIM will use Syapse,s precision ...
Breaking Medicine Technology:Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 2Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 3
... , NEW YORK , Jan. 25 ... of Kinray announced today a substantial donation to charitable organizations ... the largest privately-held distributor of pharmaceutical, generic, health & beauty ... is listed as #183 according to 2009 Forbes Magazine. , ...
... , PLEASANTON, Calif. ... a world leader in device-based mechanical circulatory support therapies to save, support ... results for the 2009 fiscal year on Thursday, January 28 . ... results and operating activities open to all interested parties at 1:30 ...
Cached Medicine Technology:Pharma Billionaire Stewart Rahr Provides Substantial Donation to Haiti Charities 2Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast 2
(Date:6/2/2015)... 02, 2015 For those that have ... exposed to harmful germs, chemicals and bodily fluids from ... to an inventor from Queens Village, N.Y., their worries ... an efficient, fun, hygienic way to store and dispense ... to bugs, chemicals and germs. Furthermore, it insures that ...
(Date:6/2/2015)... CRN International has been named a 2015 Company Partner ... Connecticut state program that takes active steps to train, coach ... companies. , Platform to Employment is being delivered by ... Labor. CRN, a 40-year-old radio marketing company near New Haven, ... for its “hard work and dedication.” , CRN recently took ...
(Date:6/2/2015)... 02, 2015 The health care leaders ... pioneering provider of value-based care will now offer health ... and Sullivan Counties. The newly launched Crystal Run Health ... commercial Small Group Preferred Provider Organization (PPO) and Exclusive ... Healthcare’s Managing Partner and CEO, Hal Teitelbaum, MD, ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Vancouver, ... by iData Research ( http://www.idataresearch.com ), the bone ... demineralized bone matrices (DBM) over traditional allograft materials. ... incisions and thus an increase in operation time, ... strong market growth in these synthetic materials is ...
(Date:6/2/2015)... 02, 2015 Relias Learning ... solutions for the healthcare market, is partnering with ... offer 10 complimentary courses relating to mental health ... professionals with additional resources to better understand and ... often the first responders to situations involving people ...
Breaking Medicine News(10 mins):Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 3Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3
... of HIV infection than non-smokers, reveals an analysis ... the journal Sexually Transmitted// Infections. ,Cigarette ... than normal chance of contracting other infections generally, ... ,The researchers trawled through 13 academic research ...
... American Dental Association (ADA) reported that serious damage of oral ... This drug harms the ability of chewing.// ,The ... over 12 million Americans have used methamphetamine, also called meth, ... or smoked. Most of the users are of the age ...
... and Hezbollah in Lebanon made a normally tense situation ... Emanuel Hanski, HHMI// international research scholars from Israel, have ... lab to join the military, not knowing when or ... tanks to check up on their research," says Michaeli. ...
... of Medicine researchers have found high rates of hunger ... western North Carolina,// southwestern Virginia and Forsyth County. ... of hunger, there are segments of the N.C. population ... areas of persistent poverty like Appalachia,” said Sara A. ...
... study has indicated that the Human papillomavirus (HPV) could ... Human papillomavirus is// associated with the growth of warts, ... ,Researchers from New York Hospital-Cornell Medical ... had only a 50% chance of conception through the ...
... here Monday in his bid to complete 24 such runs in ... cancer// research. ,"The 'Great World Run' is my greatest ... run 314.4 miles between Sep 7 and Oct 1, and travel ... final run will be at Newcastle upon Tyne in Britain Oct ...
Cached Medicine News:Health News:Methamphetamine causes severe oral health damage 2Health News:Surveys Find Outright Hunger among Latino Immigrants in North Carolina 2Health News:Surveys Find Outright Hunger among Latino Immigrants in North Carolina 3
... are packaged in single-use foil-laminated ... is saturated with precisely the ... package is terminally sterilized, ensuring ... the patient. Swabstick provides excellent ...
... All Povidone Iodine 'Prep' ... skin and mucous membrane ... procedures. All Povidone Iodine ... solutions with surfactants. Each ...
... BETADINE Solution ... of 10% povidone-iodine. It ... antiseptic that kills gram-positive ... antibiotic resistant organisms), as ...
... This multi-purpose topical gel contains 10% Povidone ... germicidal action. As a pre-operative prep, Povidone ... of prepping solutions under the patient, thus ... Gel is also approved as a one ...
Medicine Products: